Related references
Note: Only part of the references are listed.Hypoalbuminemia in COVID-19: assessing the hypothesis for underlying pulmonary capillary leakage
M. A. Wu et al.
JOURNAL OF INTERNAL MEDICINE (2021)
Ivermectin: An Anthelmintic, an Insecticide, and Much More
Richard J. Martin et al.
TRENDS IN PARASITOLOGY (2021)
Molecular Docking Reveals Ivermectin and Remdesivir as Potential Repurposed Drugs Against SARS-CoV-2
Ahmad F. Eweas et al.
FRONTIERS IN MICROBIOLOGY (2021)
Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19 A Randomized Clinical Trial
Eduardo Lopez-Medina et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach
Abhigyan Choudhury et al.
FUTURE VIROLOGY (2021)
Coronavirus biology and replication: implications for SARS-CoV-2
Philip V'kovski et al.
NATURE REVIEWS MICROBIOLOGY (2021)
The broad spectrum antiviral ivermectin targets the host nuclear transport importin alpha/beta 1 heterodimer
Sundy N. Y. Yang et al.
ANTIVIRAL RESEARCH (2020)
Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China
Aiping Wu et al.
CELL HOST & MICROBE (2020)
COVID-19 and the cardiovascular system
Ying-Ying Zheng et al.
NATURE REVIEWS CARDIOLOGY (2020)
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
Qihui Wang et al.
CELL (2020)
Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19
Annsea Park et al.
CELL HOST & MICROBE (2020)
Prioritization of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics
Usman Arshad et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis
Zhaohai Zheng et al.
JOURNAL OF INFECTION (2020)
Plasma CRP level is positively associated with the severity of COVID-19
Wei Chen et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2020)
Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study
Shufa Zheng et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Smell and taste dysfunction in patients with COVID-19
Michael S. Xydakis et al.
LANCET INFECTIOUS DISEASES (2020)
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
Bo Diao et al.
FRONTIERS IN IMMUNOLOGY (2020)
Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?
Ulf Andersson et al.
MOLECULAR MEDICINE (2020)
Ivermectin, antiviral properties and COVID-19: a possible new mechanism of action
Emanuele Rizzo
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2020)
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Maximilian Ackermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution
Uddalak Bharadwaj et al.
PHARMACOLOGICAL REVIEWS (2020)
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Leon Caly et al.
ANTIVIRAL RESEARCH (2020)
Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen
Fatemeh Heidary et al.
JOURNAL OF ANTIBIOTICS (2020)
Attenuated Interferon and Proinflammatory Response in SARS-CoV-2-Infected Human Dendritic Cells Is Associated With Viral Antagonism of STAT1 Phosphorylation
Dong Yang et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
An aberrant STAT pathway is central to COVID-19
Toshifumi Matsuyama et al.
CELL DEATH AND DIFFERENTIATION (2020)
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Jerome Hadjadj et al.
SCIENCE (2020)
Ivermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2
Steven Lehrer et al.
IN VIVO (2020)
Ivermectin reverses the drug resistance in cancer cells through EGFR/ERK/Akt/NF-B pathway
Lu Jiang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
The PAK1-Stat3 Signaling Pathway Activates IL-6 Gene Transcription and Human Breast Cancer Stem Cell Formation
Ji-Hyang Kim et al.
CANCERS (2019)
ATP Evokes Ca2+ Responses and CXCL5 Secretion via P2X(4) Receptor Activation in Human Monocyte-Derived Macrophages
Janice A. Layhadi et al.
JOURNAL OF IMMUNOLOGY (2018)
Serious Neurological Adverse Events after Ivermectin-Do They Occur beyond the Indication of Onchocerciasis?
Rebecca E. Chandler
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2018)
Lack of Clinical Pharmacokinetic Studies to Optimize the Treatment of Neglected Tropical Diseases: A Systematic Review
Luka Verrest et al.
CLINICAL PHARMACOKINETICS (2017)
P2X4 Receptor Function in the Nervous System and Current Breakthroughs in Pharmacology
Leanne Stokes et al.
FRONTIERS IN PHARMACOLOGY (2017)
Antihypertrophic Effects of Small Molecules that Maintain Mitochondrial ATP Levels Under Hypoxia
Hiroaki Nagai et al.
EBIOMEDICINE (2017)
NF-kappa B signaling in inflammation
Ting Liu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2017)
Ivermectin Induces Cytostatic Autophagy by Blocking the PAK1/Akt Axis in Breast Cancer
Qianhui Dou et al.
CANCER RESEARCH (2016)
Long-Lasting WNT-TCF Response Blocking and Epigenetic Modifying Activities of Withanolide F in Human Cancer Cells
Chandan Seth et al.
PLOS ONE (2016)
Structural basis and functional analysis of the SARS coronavirus nsp14-nsp10 complex
Yuanyuan Ma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
MERS-CoV papain-like protease has deISGylating and deubiquitinating activities
Anna M. Mielech et al.
VIROLOGY (2014)
Challenges and opportunities of drug repositioning.
Natalia Novac
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Anti-inflammatory effects of ivermectin in mouse model of allergic asthma
Shuhan Yan et al.
INFLAMMATION RESEARCH (2011)
Ivermectin, 'Wonder drug' from Japan: the human use perspective
Andy Crump et al.
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2011)
Avermectin exerts anti-inflammatory effect by downregulating the nuclear transcription factor kappa-B and mitogen-activated protein kinase activation pathway
Xinxin Ci et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2009)
The pharmacokinetics and interactions of ivermectin in humans - A mini-review
Aranzazu Gonzalez Canga et al.
AAPS JOURNAL (2008)
Ivermectin inhibits LPS-induced production of inflammatory cytokines and improves LPS-induced survival in mice
X. Zhang et al.
INFLAMMATION RESEARCH (2008)
Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic Reticulum/Golgi membrane
Matthew Frieman et al.
JOURNAL OF VIROLOGY (2007)
Mechanism of ivermectin facilitation of human P2X4 receptor channels
A Priel et al.
JOURNAL OF GENERAL PHYSIOLOGY (2004)
Share Paper
